Search company, investor...

Founded Year



Grant | Alive

Total Raised


Last Raised

$4.3M | 2 yrs ago

About MigVax

MigVax is a company focused on the development of vaccines, specifically within the healthcare and biotechnology sectors. The company's main product is a novel oral subunit COVID-19 vaccine, which is designed to generate multiple types of immunological responses for comprehensive protection against viral infections. The vaccine is intended to be easy to administer and stable at room temperature, making it potentially more accessible and convenient than some existing vaccines. It was founded in 2020 and is based in Qiryat Shmona, Israel.

Headquarters Location

Tarshish St. Hazafon

Qiryat Shmona, 11016,





Latest MigVax News

Oligonucleotide Synthesis Market Size, Emerging Evolution and Opportunities Till 2030 | Abbott Lab, Amgen, Biogen.

May 10, 2023

News Provided By Share This Article Oligonucleotide Synthesis Market Oligonucleotides are short DNA or RNA molecules and have specific sequence of nucleotide residue, which makes an entire molecule. BURLINGAME, CALIFORNIA, UNITED STATES, May 10, 2023 / / -- "Coherent Market Insights offers a 25% discount on Oligonucleotide Synthesis Market Reports on Single User Access and Unlimited User Access" Oligonucleotide Synthesis Market Size Projections : The global oligonucleotide synthesis market is estimated to be valued at US$ 2,874.1 Million in 2022 and is expected to exhibit a CAGR of 11.3% during the forecast period (2023-2030). Short DNA or RNA molecules known as oligonucleotides have a fixed sequence of nucleotide residues that together form a complete molecule. To create a duplex chain, oligonucleotides quickly bind in a certain sequencing manner to the corresponding DNA-RNA oligonucleotide. In general testing, research, and forensics, oligonucleotides are chemically created molecular chains having phosphoramidite components made from naturally occurring or chemically altered nucleosides. [140+ Pages Research Study] Coherent Market Insight has released a new research study titled Oligonucleotide Synthesis Market is growing rapidly, which signifies a strong interest in Oligonucleotide Synthesis research as we enter 2023. Today’s business leaders face an endless stream of decisions around target markets, pricing, promotion, distribution channels, and product features and benefits. They must account for all the factors involved, and there are market research studies and methodologies strategically designed to capture meaningful data to inform every choice. Ask Us to Get Your Sample Copy Of The Report, Covering TOC and Regional Analysis @ Note – Updated Version 2023 is available (The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.) Our Sample Report May Includes: ⁍ 2030 Updated Report Introduction, Overview, and In-depth industry analysis. ⁍ 100+ Pages Research Report (Inclusion of Updated Research). ⁍ Provide Chapter-wise guidance on Requests. ⁍ 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends ⁍ Includes Updated List of tables & figures. ⁍ Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis. Competitive Landscape: The given section on the global Oligonucleotide Synthesis Market will include an extensive examination of the various players in this industry, their respective company overviews, an analysis of existing product portfolios, financials, etc. We even include a supply-chain analysis, a PEST analysis, market probability scenarios, Porter’s Five Forces analysis, and other related frameworks that are meant to aid in the expansion of your reputed organization. The specific application of these given findings allows all our clients to apply essential yet accurate data when formulating the most-suitable business strategies with the aim of improving their business’ footprint in this global industry. Top Key Players: Abbott Laboratories, Amgen, Inc., Biogen, Inc, Eily, Lilly, and Company, F. Hoffmann-La Roche, Johnson and Johnson, Merck & Co., Novo Nordisk, Pfizer, Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Emergent Biosolutions Inc. , TransAlgae, MigVax Ltd, and Lumen Bioscience, Inc This report also splits the market by region: Americas, United States, Canada, Mexico, Brazil, APAC, China, Japan, Korea, Southeast Asia, India, Australia, Europe, Germany, France, UK, Italy, Russia, Spain, Middle East and Africa, Egypt, South Africa, Israel, Turkey, GCC Countries For Additional List and Detail Information on Key Players, Send Your Request for Custom Report@ Research Methodology: ➣ 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐝𝐞𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧 – A detailed description of the company’s operations and business divisions. ➣ 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐲 – Analyst’s summarization of the company’s business strategy. ➣ 𝐒𝐖𝐎𝐓 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 – A detailed analysis of the company’s strengths, weakness, opportunities and threats. ➣ 𝐂𝐨𝐦𝐩𝐚𝐧𝐲 𝐡𝐢𝐬𝐭𝐨𝐫𝐲 – Progression of key events associated with the company. ➣ 𝐌𝐚𝐣𝐨𝐫 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐚𝐧𝐝 𝐬𝐞𝐫𝐯𝐢𝐜𝐞𝐬 – A list of major products, services and brands of the company. ➣ 𝐊𝐞𝐲 𝐜𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐨𝐫𝐬 – A list of key competitors to the company. ➣ 𝐈𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭 𝐥𝐨𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐚𝐧𝐝 𝐬𝐮𝐛𝐬𝐢𝐝𝐢𝐚𝐫𝐢𝐞𝐬 – A list and contact details of key locations and subsidiaries of the company. ➣ 𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐟𝐢𝐧𝐚𝐧𝐜𝐢𝐚𝐥 𝐫𝐚𝐭𝐢𝐨𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐩𝐚𝐬𝐭 𝐟𝐢𝐯𝐞 𝐲𝐞𝐚𝐫𝐬 – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐔𝐩 𝐓𝐨 𝟐𝟓% 𝐎𝐅𝐅 @ Purchasing the Oligonucleotide Synthesis Market for the Following Reasons: ⋆The study examines emerging market trends as well as the likelihood that various trends will impact expansion. ⋆The analysis also discusses the factors, challenges, and opportunities that will have a significant impact on the global Oligonucleotide Synthesis industry. ⋆ Technological tools and benchmarks that reflect the industry’s projected growth of the Oligonucleotide Synthesis industry. ⋆ The research includes a detailed analysis of market statistics as well as historical and current growth conditions in order to provide futuristic growth estimates. ⋆The research includes a detailed analysis of market statistics as well as historical and current growth conditions in order to provide futuristic growth estimates. Table of Contents with Major Points: Executive Summary Why Choose Coherent Market Insights? ☛ Identified business opportunities – Our market research report can be used to analyze potential markets and new products. It can give information about customer needs, preferences, and attitudes. Also, it compare products and services. ☛ A clear understanding of your customers – A market report gives company’s marketing department an in-depth picture about customers’ needs and wants. This knowledge can be used to improve products, prices, and advertising. ☛ Clear data-driven insights – Our Market research encompasses a wide range of activities, from determining market size and segment to forecasting demand, and from identifying competitors to monitoring pricing. All of these are quantified and measurable which means that gives you a clear path for building unique decisions based on numbers. About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S., and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 32 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends, and new working methods. Mr. Shah +1 206-701-6702

MigVax Frequently Asked Questions (FAQ)

  • When was MigVax founded?

    MigVax was founded in 2020.

  • Where is MigVax's headquarters?

    MigVax's headquarters is located at Tarshish St., Qiryat Shmona.

  • What is MigVax's latest funding round?

    MigVax's latest funding round is Grant.

  • How much did MigVax raise?

    MigVax raised a total of $16.3M.

  • Who are the investors of MigVax?

    Investors of MigVax include Coalition for Epidemic Preparedness Innovations and OurCrowd.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.